Cabbacis Reports First Half 2026 Financial Results and Provides Corporate Update

For best results when printing this announcement, please click on link below: Cabbacis Reports First Half 2026 Financial Results and Provides Corporate Update Cabbacis (OTCQB: CABI ), a U.S. federally-licensed tobacco-product manufacturer focused on risk-reduction products being developed under the iBLEND™ and X95™ brand names, today announced that it has filed its Semiannual Report on Form 1-SA for the six-month period ending June 30, 2026 with the U.S. Securities and Exchange Commission (the “SEC”). First Half 2026 Financial Results and Company Highlights The Company’s net loss in the first half of 2026 was $1,343,291, as compared to $735,560 in the first half of 2025, with the increase primarily reflecting higher non-cash, stock-based compensation expense. Basic and diluted earnings (loss) per common share were ($0.18), as compared to ($0.12) in the prior-year.